What is the share price of Balaxi Pharmaceuticals Ltd (BALAXI) today?
The share price of BALAXI as on 10th July 2025 is ₹49.86. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Balaxi Pharmaceuticals Ltd (BALAXI) share?
The past returns of Balaxi Pharmaceuticals Ltd (BALAXI) share are- Past 1 week: 0.85%
- Past 1 month: -12.18%
- Past 3 months: -25.30%
- Past 6 months: -30.88%
- Past 1 year: -55.90%
- Past 3 years: -31.20%
- Past 5 years: 99.44%
What are the peers or stocks similar to Balaxi Pharmaceuticals Ltd (BALAXI)?
The peers or stocks similar to Balaxi Pharmaceuticals Ltd (BALAXI) include:What is the market cap of Balaxi Pharmaceuticals Ltd (BALAXI) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Balaxi Pharmaceuticals Ltd (BALAXI) is ₹275.26 Cr as of 10th July 2025.What is the 52 week high and low of Balaxi Pharmaceuticals Ltd (BALAXI) share?
The 52-week high of Balaxi Pharmaceuticals Ltd (BALAXI) is ₹129.44 and the 52-week low is ₹48.53.What is the PE and PB ratio of Balaxi Pharmaceuticals Ltd (BALAXI) stock?
The P/E (price-to-earnings) ratio of Balaxi Pharmaceuticals Ltd (BALAXI) is 10.98. The P/B (price-to-book) ratio is 1.37.Which sector does Balaxi Pharmaceuticals Ltd (BALAXI) belong to?
Balaxi Pharmaceuticals Ltd (BALAXI) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Balaxi Pharmaceuticals Ltd (BALAXI) shares?
You can directly buy Balaxi Pharmaceuticals Ltd (BALAXI) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Balaxi Pharmaceuticals Ltd
BALAXI Share Price
BALAXI Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
BALAXI Performance & Key Metrics
BALAXI Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
10.98 | 1.37 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
36.59 | 6.40 | 0.79% |
BALAXI Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
BALAXI Company Profile
The company is engaged in wholesale trading of pharmaceuticals products, food products and builders’ hardware products. The Company offers a range of food and biscuit products under the brand name YAP.
BALAXI Forecast
BALAXI Forecasts
BALAXI
BALAXI
Income
Balance Sheet
Cash Flow
BALAXI Income Statement
BALAXI Income Statement
Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 14.49 | 46.22 | 233.56 | 284.36 | 339.07 | 241.92 | 288.84 | 288.84 | ||||||||
Raw Materials | 0.00 | 32.83 | 172.15 | 195.60 | 202.42 | 128.68 | 255.35 | 255.34 | ||||||||
Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.35 | 0.28 | 0.04 | ||||||||||
Employee Cost | 0.90 | 2.10 | 8.47 | 12.47 | 28.95 | 28.04 | ||||||||||
Selling & Administrative Expenses | 0.59 | 1.75 | 4.74 | 17.56 | 42.29 | 36.02 | ||||||||||
Operating & Other expenses | 10.55 | 0.70 | 3.30 | 2.59 | 5.08 | 42.27 | ||||||||||
EBITDA | 2.45 | 8.84 | 44.90 | 55.79 | 60.05 | 6.87 | 33.49 | 33.50 | ||||||||
Depreciation/Amortization | 0.00 | 0.01 | 0.30 | 0.51 | 1.75 | 2.10 | 1.89 | 1.89 | ||||||||
PBIT | 2.45 | 8.83 | 44.60 | 55.28 | 58.30 | 4.77 | 31.60 | 31.61 | ||||||||
Interest & Other Items | 0.00 | 0.05 | 0.28 | 0.76 | 1.38 | 2.77 | 2.93 | 2.94 | ||||||||
PBT | 2.45 | 8.78 | 44.32 | 54.52 | 56.92 | 2.00 | 28.67 | 28.67 | ||||||||
Taxes & Other Items | 0.47 | 2.69 | 6.19 | 6.86 | 10.96 | 4.40 | 3.60 | 3.59 | ||||||||
Net Income | 1.98 | 6.09 | 38.13 | 47.66 | 45.96 | -2.40 | 25.07 | 25.08 | ||||||||
EPS | 1.30 | 1.87 | 7.63 | 9.53 | 9.11 | -0.46 | 4.54 | 4.60 | ||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
BALAXI Company Updates
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
BALAXI Stock Peers
BALAXI Past Performance & Peer Comparison
BALAXI Past Performance & Peer Comparison
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Balaxi Pharmaceuticals Ltd | 10.98 | 1.37 | — |
Inventurus Knowledge Solutions Ltd | 54.35 | 22.81 | — |
Poly Medicure Ltd | 66.43 | 15.30 | 0.15% |
Laxmi Dental Ltd | 75.27 | 53.67 | — |
BALAXI Stock Price Comparison
Compare BALAXI with any stock or ETFBALAXI Holdings
BALAXI Shareholdings
BALAXI Promoter Holdings Trend
BALAXI Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
BALAXI Institutional Holdings Trend
BALAXI Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
BALAXI Shareholding Pattern
BALAXI Shareholding Pattern
BALAXI Shareholding History
BALAXI Shareholding History
smallcases containing BALAXI stock
smallcases containing BALAXI stock
Looks like this stock is not in any smallcase yet.
BALAXI Events
BALAXI Events
BALAXI Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
BALAXI Dividend Trend
No dividend trend available
BALAXI Upcoming Dividends
BALAXI Upcoming Dividends
No upcoming dividends are available
BALAXI Past Dividends
BALAXI Past Dividends
Cash Dividend
Ex DateEx DateJul 1, 2022
Dividend/Share
₹0.50
Ex DateEx Date
Jul 1, 2022
BALAXI Stock News & Opinions
BALAXI Stock News & Opinions
Balaxi Pharmaceuticals announced that the 82th Annual General Meeting(AGM) of the company will be held on 25 August 2025.Powered by Capital Market - Live
Net profit of Balaxi Pharmaceuticals declined 20.95% to Rs 8.64 crore in the quarter ended March 2025 as against Rs 10.93 crore during the previous quarter ended March 2024. Sales rose 27.48% to Rs 76.27 crore in the quarter ended March 2025 as against Rs 59.83 crore during the previous quarter ended March 2024. For the full year,net profit declined 30.19% to Rs 25.07 crore in the year ended March 2025 as against Rs 35.91 crore during the previous year ended March 2024. Sales rose 21.25% to Rs 292.56 crore in the year ended March 2025 as against Rs 241.29 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales76.2759.83 27 292.56241.29 21 OPM %16.4522.51 -12.7219.37 - PBDT10.1211.07 -9 30.5642.41 -28 PBT9.6610.40 -7 28.6740.31 -29 NP8.6410.93 -21 25.0735.91 -30 Powered by Capital Market - Live
Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
Net profit of Balaxi Pharmaceuticals declined 60.56% to Rs 5.36 crore in the quarter ended December 2024 as against Rs 13.59 crore during the previous quarter ended December 2023. Sales rose 20.56% to Rs 73.29 crore in the quarter ended December 2024 as against Rs 60.79 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales73.2960.79 21 OPM %5.4422.47 - PBDT6.5513.11 -50 PBT6.0712.63 -52 NP5.3613.59 -61 Powered by Capital Market - Live
Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 February 2025.Powered by Capital Market - Live
Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September 2024 as against Rs 14.43 crore during the previous quarter ended September 2023. Sales rose 41.41% to Rs 77.38 crore in the quarter ended September 2024 as against Rs 54.72 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales77.3854.72 41 OPM %13.6919.66 - PBDT6.0310.67 -43 PBT5.5610.01 -44 NP4.5914.43 -68 Powered by Capital Market - Live
Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November 2024Powered by Capital Market - Live
Net profit of Balaxi Pharmaceuticals reported to Rs 6.48 crore in the quarter ended June 2024 as against net loss of Rs 41.34 crore during the previous quarter ended June 2023. Sales declined 0.52% to Rs 65.62 crore in the quarter ended June 2024 as against Rs 65.96 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales65.6265.96 -1 OPM %15.3813.40 - PBDT7.877.54 4 PBT7.377.26 2 NP6.48-41.34 LP Powered by Capital Market - Live
Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company will be held on 23 August 2024.Powered by Capital Market - Live
Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 August 2024.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 44.27%, vs industry avg of 24.47%
Over the last 5 years, market share increased from 2.18% to 3.98%
Over the last 5 years, net income has grown at a yearly rate of 32.71%, vs industry avg of 28.87%